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Abstract 31 
Objectives: In this report, the second-generation 32 
high-intensity focused ultrasound (HIFU) systems were clinically 33 
evaluated for human fetal therapy in two cases of twin reversed 34 
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arterial perfusion sequence. 35 
Methods: The HIFU systems comprised an improved lead 36 
zirconate-titanate transducer with an imaging phase array sector 37 
probe, a Sonachill cooling system, and three phases of HIFU 38 
exposure: a trigger pulse, a continuous heating wave, and an idle 39 
period to obtain images with the imaging probe set on the transducer. 40 
To evaluate skin surface temperature, a thermal camera was used. 41 
To evaluate vessel occlusions, blood flow were measured at fixed 42 
timings after exposures.  43 
Results: Target vessel occlusion was achieved with HIFU in 44 
only one of the cases, but recanalization occurred the day after. Both 45 
cases were finally treated with radiofrequency ablation and one infant 46 
was successfully delivered without any complications.  47 
Conclusions: This case highlighted three advantages with the 48 
change to second-generation HIFU systems in human fetal therapy: 49 
the simplicity of maneuvers by reduced range of motion disturbance; 50 
the ability to observe in real time during the exposure; and a 51 
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decrease in total ultrasonic output. Treatment interruption due to 52 
burns or complaints of heat sensation represented an obstruction on 53 
treatment completion. This remains an issue to be addressed in the 54 
future. 55 
 56 
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 59 
Introduction 60 
High-intensity focused ultrasound (HIFU) is a non-invasive 61 
therapeutic tool that causes biological reactions (such as thermal 62 
denaturation) at the target. HIFU has two main effects, thermal and 63 
non-thermal. Thermal effects are due to target absorption of the 64 
ultrasound radiation, while the non-thermal effects derive from 65 
cavitation, micro-streaming, and acoustic streaming. Specifically, the 66 
cavitational effect describes physical forces generated by the 67 
ultrasound waves. These physical effects manifest as characteristic 68 
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compression and rarefaction resulting in micro-gas bubbles that 69 
contract and expand the tissue. It is generally thought that the rapid 70 
changes in pressure associated with cavitation, both in and around 71 
the cell, can cause cellular damage [1,2]. Capitalizing on these 72 
effects, HIFU therapy has been already applied in the clinical setting 73 
for the treatment of prostate cancer, [3] breast cancer, [4] and uterine 74 
myoma. [5] 75 
Twin reversed arterial perfusion sequence (TRAPs) is a 76 
relatively rare complication, affecting 1 in 35,000 monochorionic twin 77 
pregnancies [6]. If TRAPs is left untreated, the mortality rate of the 78 
pump fetus is approximately 55% [7], with spontaneous resolution of 79 
up to 21% [8]. Various treatment methods have been reported, such 80 
as cord occlusion [9-12], anastomotic vessel ablation [13,14], and 81 
intra-acardiac fetal ablation. [15,16] Of these, radiofrequency 82 
ablation (RFA) provides good results due to its relatively low 83 
invasiveness and ease of treatment [12,17-21]. Such minimally 84 
invasive techniques reduce, but do not remove the risks, without 85 
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changing survival rates. Although TRAPs may be diagnosed from 11 86 
to 13 weeks gestation, treatment is often delayed until after 16 weeks 87 
gestation to allow time for fusion of the amnion and chorion, by which 88 
time intrauterine death of the pump twin still occurs in up to one-third 89 
of cases [8]. 90 
HIFU applied from outside the mother's abdominal wall is 91 
thought to be less invasive and provide good acoustic efficiency due 92 
to the presence of amniotic fluid in the uterus. Therefore, the fetus is 93 
likely to be a suitable target for HIFU treatment. We have reported 94 
several preclinical studies of the clinical applications of HIFU in 95 
prenatal treatment [22-25], and in 2013, we described the first 96 
successful application of HIFU as a non-invasive in utero treatment 97 
for TRAPs [26]. This successful case revealed improvements that 98 
can contribute to safer and less invasive treatment. First, we could 99 
not obtain real-time images during the exposure, because HIFU and 100 
imaging signals interfere with each other. Second, there were motion 101 
range disturbances during scanning (because a large biaxial device 102 
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was used, and because the imaging probe was located lateral to the 103 
HIFU transducer). Finally, the exposure was insufficient in some 104 
cases because the patients complained of a burning sensation 105 
during exposure. To overcome these challenges second-generation 106 
HIFU systems have been developed (Fig 1.) [25,26]. The present 107 
study evaluated a second-generation HIFU system to not only 108 
clinically evaluate its efficacy, but also investigate the adverse effects 109 
of such systems. 110 
 111 
Material and Methods 112 
(1) The HIFU transducer and systems 113 
A lead zirconate-titanate (PZT) transducer with a resonant 114 
frequency of 1.1 MHz and a focal distance of 60 mm was used with a 115 
phased array sector probe for imaging (Hitachi Aloka Medical Ltd., 116 
Tokyo, Japan) at an operating frequency of 1-5 MHz. A SONACHILL 117 
cooling system was used (SONABLATE 500; SonaCare Medical, 118 
LLC., NC, USA), supplied with circulating, degassed, cooled water. 119 
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The first-generation HIFU units were large biaxial units. In contrast, 120 
in second-generation HIFU units, the transducer has a hole in the 121 
center and the imaging probe is arranged coaxially within the hole 122 
(contained within aluminum housing). (Fig 1.) [25,26]. There are two 123 
holes in the upper part of the aluminum housing in the 124 
second-generation units that are connected to the SONACHILL 125 
cooling system. They are sealed with a latex-free ultrasound probe 126 
cover (sterile 17.8 x 147 cm telescopically-folded cover CIV-FLEX, 127 
CIVCO. IA, USA). Circulating, degassed, cooled water is contained 128 
within the aluminum housing and the probe cover (Fig 1.). In this 129 
study, the HIFU was driven by a radiofrequency (RF) amplifier (RF 130 
Power Amplifier Model 1040L; Electronics and Innovation, Ltd., 131 
Rochester, NY, USA), and the input signal to the amplifier was 132 
transferred by a function generator (DS5614, Iwatsu test instruments 133 
Corp., Tokyo, Japan). The skin surface temperature was measured 134 
using a thermal camera (FLIR CPA-T620; CHINO Corp., Tokyo, 135 
Japan). The error of the camera is ± 2% or ± 2°C.  136 
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 137 
(2) HIFU exposures 138 
A successful first-generation HIFU exposure uses a 139 
continuous exposure pattern (focal length, 60 mm; frequency, 1.71 140 
MHz; ISATA, 2.3 kW/cm2, 4.6 kW/cm2; duration, 10 sec). In 141 
second-generation units, the HIFU exposure consists of three 142 
phases. The first phase is a trigger pulse to produce the cavitation 143 
(frequency, 1.10 MHz; ISATA, 5.8 kW/cm2; duration, 0.1 ms). The 144 
second phase is a continuous heating wave to oscillate the bubbles 145 
generated by cavitation (frequency, 1.10 MHz; ISATA, 1.5 kW/cm2; 146 
duration, 94.5 ms). The third phase is an idle period (duration, 5.4 147 
ms) that is used to obtain images used an ultrasound probe during 148 
the HIFU exposure. A single HIFU exposure generally lasts for 149 
approximately 100 ms (10 repeats per second, 10 Hz), and is 150 
represented schematically in Fig 2. The trigger HIFU sequence was 151 
developed as a cavitation-assisted ultrasonic heating method. 152 
[27,28] By using a high-speed camera [27] and ultrasonic imaging 153 
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[28], the occurrence of inertial cavitation was observed. Ablation 154 
performance and total ultrasonic output reduction was reported by a 155 
previous study that was carried out similarly [29]. 156 
 157 
(3) Subjects of the study 158 
Case 1: A 40-year-old primigravida woman who was 159 
pregnant with twins was referred to our hospital at 14 weeks of 160 
gestation due to the absence of a heartbeat in one fetus. TRAPs was 161 
diagnosed based on the ultrasonographic findings. HIFU therapy 162 
was performed at 14 weeks and 6 days of gestation. The maternal 163 
abdominal thickness and myometrium was approximately 30 mm. 164 
Case 2: A 32-year-old primigravida woman who was pregnant with 165 
twins was referred to our hospital at 14 weeks of gestation due to the 166 
absence of a heart beat in one fetus. TRAPs was diagnosed based 167 
on the ultrasonographic findings, and HIFU therapy was performed 168 
at 14 weeks and 5 days of gestation. The maternal abdominal 169 
thickness and myometrium was 25 mm, and the placenta thickness 170 
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was 20 mm.  171 
 172 
(4) Clinical settings of HIFU exposures 173 
The patients were treated in the supine position as for a 174 
normal ultrasound scan. Umbilical cord insertion into the body of the 175 
acardiac fetus was evaluated by color Doppler imaging. The chosen 176 
HIFU protocol involved exposure repeated 15 times in an 8-second 177 
cycle, even if interruption of the blood flow was seen during the 178 
exposure protocol. Exposure was performed with the aim of blocking 179 
arteries and veins simultaneously. This protocol was determined 180 
from the findings obtained in basic studies [22-26,29]. 181 
Just after exposure, the bag was released from the maternal 182 
abdominal wall and the temperature of the skin surface was 183 
measured using a highly precise thermal camera (during exposure, 184 
just after exposure, 30 seconds later, and 60 seconds later). 185 
Exposed blood vessels were observed by color Doppler and pulse 186 
wave Doppler imaging (just after exposure, 1 hour later, 3 hours later, 187 
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and the next morning). Measurements were made with a Doppler 188 
incidence angle correction of ±10°, and the results of 5 189 
measurements were averaged. 190 
 191 
The methods were carried out in accordance with relevant 192 
guidelines and regulations of the “Ethical Guidelines for Medical and 193 
Health Research Involving Human Subjects” (Japan, 2015). All 194 
experimental protocols were approved by Showa University School 195 
of Medicine Ethics Committee (Permission number: 700), and written 196 
informed consent was obtained from each patient before the study. 197 
 198 
Results 199 
Clinical courses 200 
Case 1: With a distance to the focal point of 55 mm, matching 201 
the focus to the HIFU target required circulating, degassed, cooled 202 
water adjusted to a distance of 5 mm from transducer to abdominal 203 
wall. Eight cycles of HIFU exposure were administered. Although 15 204 
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courses were planned, HIFU exposure was stopped in this case 205 
because the patient complained of a burning sensation during the 8th 206 
exposure. Vessel stenosis and reduced blood flow were confirmed, 207 
but complete occlusion was not confirmed. The vessel stenosis and 208 
reduced blood flow were still apparent the next day, and a high level 209 
of brightness was observed at the site of exposure; occlusion was 210 
still not confirmed (Table 1; Fig 3.). After the HIFU therapy, this 211 
patient visited her previous hospital at 15 weeks and 5 days of 212 
gestation and an ultrasound scan was performed. The acardiac 213 
twin’s umbilical artery resistance index (UmA-RI) was 0.63, and peak 214 
systolic velocity (PSV) was 23.1 cm2/s. There were no changes 215 
compared with the pre-exposure parameters, she underwent a RFA 216 
at 16 weeks and 5 days of gestation. Combined spinal epidural 217 
anesthesia (CSEA) was administered, and the operation time was 27 218 
min (5 mm 30 W, 20 s; 10 mm 30 W, 47 s; 15 mm 30-40 W, 90 s; 40 219 
W, 102 s). She was discharged 2 days after the operation, and her 220 
prenatal course after the RFA treatment was uncomplicated. 221 
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Cesarean section was performed at 37 weeks of gestation due to 222 
placenta previa, and a 2246-g male infant was delivered with Apgar 223 
scores of 8 at 1 minute and 9 at 5 minutes. 224 
Case 2: With a distance to the focal point of 45 mm and in 225 
order to match the focus to the target, the amount of circulating, 226 
degassed, cooled water was adjusted to provide a distance of 10 mm 227 
between the transducer and abdominal wall. Eight cycles of HIFU 228 
exposure were administered. The blood flow disappeared after the 229 
7th cycle. As with case 1, this case ended with insufficient exposure, 230 
because a burn was detected on the mother's abdominal wall during 231 
the 8th exposure and the planned 15 exposures were not completed. 232 
The next day, vessel stenosis, reduced blood flow, and high 233 
brightness on the ultrasound image were confirmed at the site of 234 
exposure; however, the occluded vessels had recanalized (Table 2; 235 
Fig 4.). After HIFU therapy, the woman visited her previous hospital 236 
at 15 weeks and 3 days of gestation. An ultrasound scan showed 237 
that the acardiac twin's UmA-RI was 0.63, and the PSV was 29.9 238 
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cm2/s. There were no changes compared with the pre-exposure 239 
parameters. The patient underwent RFA treatment at 16 weeks and 240 
4 days of gestation; she received CSEA anesthesia, and the 241 
operation time was 12 min (10 mm 30 W, 30 s; 15 mm 30 W, 50 s). 242 
She was discharged one day after the operation, and her prenatal 243 
course after the RFA treatment was uncomplicated. The woman 244 
gave birth by normal spontaneous vaginal delivery at 39 weeks and 4 245 
days of gestation. A 2870-g male infant was born with Apgar scores 246 
of 8 at 1 minute and 8 at 5 minutes. 247 
Neither case involved complications to the pump fetus. In 248 
terms of maternal complications, case 1 had redness and a 249 
first-degree burn, while case 2 showed blistering and was diagnosed 250 
with a second-degree burn. The condition of Case 1 resolved with 251 
follow-up alone, while the condition of Case 2 resolved with steroid 252 
ointment treatment for 2 weeks. No lasting discoloration of the skin or 253 
scarring was apparent. 254 
 255 
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Evaluation of clinical usage for HIFU 256 
First-generation HIFU systems suffered from a wide range of 257 
motion range disturbances, and coherence could not be achieved 258 
between the apparatus and the abdominal wall because the system 259 
itself was a large, biaxial unit [25,26]. In second-generation HIFU 260 
devices, the imaging probe is arranged in the center of the HIFU 261 
transducer and is a small, coaxial device thus it is subjected to less 262 
motion range disturbance. Coherence between the apparatus and 263 
the abdominal wall is achieved, and the device is more 264 
maneuverable. In the first-generation systems, the ultrasound and 265 
imaging signals interfered with each other due to the continuous 266 
exposure, but the newer devices have adopted a sequential 267 
exposure system, allowing the system to capture real-time 268 
ultrasound images in the short downtime period (Fig 2). This helps 269 
adjust for misalignment that can occur due to the patient's respiratory 270 
fluctuations, fetal movements, or tremor of the operator's hand. In 271 
addition, it allows observation of the process of tissue denaturation 272 
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during exposure (Fig 5), and increases in surface temperature are 273 
controlled using a circulating, degassed, cooled water unit (Fig 6). 274 
 275 
Discussion 276 
In case 1, the target vessels were constricted, but occlusion 277 
was not achieved just after therapy. The patient complained of a 278 
burning sensation during the 8th exposure. On the next day, vessel 279 
stenosis, reduced blood flow, and high brightness at the site of 280 
exposures were observed on the ultrasound image, but occlusion 281 
was not confirmed. It was thought that the spinal bones of the 282 
acardiac fetus had prevented sufficient acoustic energy from 283 
reaching the target, because it was in a prone position within the 284 
uterus. Indeed, no better condition for exposure could be found; 285 
however, the patient then wished to change to RFA when the HIFU 286 
treatment could not be accomplished within a single day of 287 
hospitalization. If the treatment could have been repeated without 288 
time restrictions, occlusion of blood flow may have been achieved.  289 
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In case 2, vessel occlusion was achieved at the 7th 290 
exposure; however, the case ended with insufficient exposure 291 
because a burn was detected on the mother's abdominal wall during 292 
the 8th exposure and the plan of 15 exposures was aborted. On the 293 
next day, the occluded vessels had recanalized, although vessel 294 
stenosis, reduced blood flow, and high brightness on the ultrasound 295 
image were confirmed at the site of exposures. In past reports, high 296 
echogenicity in tissue also meant histological thermal degeneration 297 
[22-24]. Similar thermal degeneration seemed to occur in the current 298 
two patients, although not to the point of permanently occluding the 299 
blood vessels. Of note, ultrasonic measurements were performed in 300 
this study; however, they were acquired using color Doppler 301 
ultrasonography, PSV, and RI.  302 
As the blood vessel narrows, the change that the PSV rises, 303 
As the blood vessel narrows, the changes that the PSV 304 
increases presented herein mirror findings from a previous preclinical 305 
study [22]. Although 15 cycles of exposures had been planned, 306 
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based on other preclinical studies, treatment was stopped due to a 307 
slight burn on the mother's abdominal wall. The distance between the 308 
target and the abdominal wall was close in case 2. Since the focal 309 
length is fixed at 60 mm by the device’s shape, the distance between 310 
the abdominal wall and the device was therefore adjusted by the 311 
amount of degassed cooled water in the probe cover. It was 312 
therefore thought that the distance between the device and the skin 313 
caused the burn. In both cases, poor conditions were partially 314 
responsible for the treatment failure, and flexibility is essential to 315 
successfully perform the treatment under good conditions. To 316 
achieve this, informed consent from the patient for conditions such 317 
as a fixed hospitalization period may be needed. 318 
The second-generation HIFU systems incorporate three 319 
significant improvements. First, the physical entity was transformed 320 
from a large biaxial unit to a small coaxial one, resulting in decreased 321 
motion range disturbance, coherence between the apparatus and the 322 
abdominal wall, and a more maneuverable device. This overall 323 
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improvement seems to have expanded the possibilities for HIFU in 324 
fetal treatment. Second, the conversion from a blind view to real-time 325 
imaging is a key improvement that enables direct observation of the 326 
target during the HIFU exposure and allows the operator to adjust 327 
any misalignment. This feature seems to have improved the safety of 328 
HIFU in fetal treatment. Third, the systems were upgraded from a 329 
non-circulating, degassed, cooled water bag to a circulating, 330 
degassed, cooled water system. The SONACHILL cooling system, 331 
which reduces the increase in skin surface temperature, was added 332 
to mediate this third improvement, although a mild burn still occurred 333 
in both cases presented herein. Thermal and non-thermal effects are 334 
present, and the information obtained by the thermal camera showed 335 
the result that skin surface temperature was low. This result suggests 336 
prevention of the thermal effect, at least on the skin surface. 337 
However, we were not actually able to prevent burns, probably due to 338 
the influence of non-thermal effects (e.g., cavitation between the 339 
probe cover and the abdominal skin surface).  340 
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In both cases, poor conditions were partly responsible for 341 
treatment failure, but they were not the sole cause. The problem of 342 
burning has not been solved, and attempts to identify recanalization 343 
and the formation of collateral circulation were insufficient. These 344 
problems need to be solved for the reliable application of HIFU in 345 
such cases. The cause of the burn was thought to be cavitation 346 
between the probe cover and the abdominal skin surface, thus a 347 
method to prevent this effect must be established. In addition, the 348 
present study showed that recanalization remains possible in cases 349 
that seem to be occluded, and HIFU treatment might only cause 350 
temporary thrombus formation or vessel spasm just after exposure. It 351 
is therefore necessary to investigate exposure intensity and the 352 
number of exposures cycles needed to achieve complete occlusion. 353 
There are three main advantages attributed to 354 
second-generation HIFU systems in the human clinical setting: the 355 
simplicity in maneuverability and reduced disturbance to the range of 356 
motion; the ability to image in real time during exposures; and the 357 
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decrease in total ultrasonic output. In the two cases presented herein, 358 
complete occlusion was not achieved, but a reduction was obtained 359 
in one patient and temporary occlusion was seen in the other. In both 360 
cases, no long-term adverse events were apparent for either the 361 
mother or the fetus. Treatment interruption due to burns or 362 
complaints of heat sensation obstructed the treatment completion, 363 
and such an outcome remains an issue to be addressed in the future. 364 
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Fig 1. HIFU systems 477 
 478 
 479 
(a) In a first-generation HIFU unit, the imaging probe is located lateral to the 480 
HIFU transducer. Therefore the device used in this study was large and 481 
biaxial. (b) In a second-generation HIFU unit, the HIFU transducer has a 482 
hole in the center, and the imaging probe is arranged coaxially within the 483 
hole (contained within aluminum housing). (c) There are two holes in the 484 
upper part of the aluminum housing in the second-generation units that are 485 
connected to the SONACHILL cooling system. They are sealed with an 486 
ultrasound probe cover. Circulatory de-aeration coolant water is contained 487 
within the aluminum housing and the probe cover. 488 
(a) (b)
(c)
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Fig 2. Schematic drawings of the irradiation sequence  489 
 490 
Vessel stenosis and reduced blood flow were confirmed, but occlusion was 491 
not completely confirmed. Similar to the next day of irradiation, vessel 492 
stenosis and reduced blood flow were detected post-irradiation, but 493 
occlusion was not confirmed. 494 
 495 
 496 
 497 
 498 
continuous wave 
Freq 1.71MHz     ISATA 2.3-4.6kW/cm2
(a)
(b)
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Fig 3. Ultrasound images pre- and post-Irradiation (case 1) 499 
 500 
 501 
The blood flow disappeared after the 7th cycle. Vessel stenosis and 502 
reduced blood flow were detected; however, 503 
 the occluded vessels had recanalized at next day. 504 
 505 
 506 
 507 
 508 
Next day
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Fig 4. Ultrasound images pre- and post-irradiation (case 2) 509 
 510 
(a) A first-generation HIFU system used a continuous irradiation pattern, (b) 511 
In contrast, second-generation HIFU systems used sequential irradiation. 512 
① A trigger pulse to produce the cavitation (frequency, 1.10 MHz; ISATA, 513 
5.8 kW/cm2; duration, 0.1 ms). ② A continuous heating wave to oscillate 514 
the bubbles generated by cavitation (frequency, 1.10 MHz; ISATA, 1.5 515 
kW/cm2; duration, 94.5 ms). ③ An idle period (duration, 5.4 ms), used to 516 
obtain an image using an imaging ultrasound probe during the HIFU 517 
irradiation. The pulse repetition frequency (PRF) during the three phases 518 
was set at 10 Hz. Total HIFU intensity was set at 1.94 kW/cm2. 519 
Next day
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Fig 5. Images during irradiation 520 
 521 
(a) Using a first-generation HIFU system, we could not obtain real-time 522 
images during irradiation, because the HIFU and imaging signals interfere 523 
with each other. (b) For the new device, a sequential irradiation system was 524 
adopted, allowing  525 
real-time ultrasound images to be captured in the short downtime period. It 526 
allows observation of the process of tissue denaturation during irradiation. 527 
 528 
(a) (b)
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Fig 6. Changes in skin surface temperature after HIFU exposure in both 529 
cases (thermal camera findings) 530 
 531 
Increases in surface temperature were controlled using a circulatory 532 
de-aeration coolant water unit in both cases. 533 
 534 
 535 
 536 
